Falegan, O.S.; Arnold Egloff, S.A.; Zijlstra, A.; Hyndman, M.E.; Vogel, H.J.
Urinary Metabolomics Validates Metabolic Differentiation Between Renal Cell Carcinoma Stages and Reveals a Unique Metabolic Profile for Oncocytomas. Metabolites 2019, 9, 155.
https://doi.org/10.3390/metabo9080155
AMA Style
Falegan OS, Arnold Egloff SA, Zijlstra A, Hyndman ME, Vogel HJ.
Urinary Metabolomics Validates Metabolic Differentiation Between Renal Cell Carcinoma Stages and Reveals a Unique Metabolic Profile for Oncocytomas. Metabolites. 2019; 9(8):155.
https://doi.org/10.3390/metabo9080155
Chicago/Turabian Style
Falegan, Oluyemi S., Shanna A. Arnold Egloff, Andries Zijlstra, M. Eric Hyndman, and Hans J. Vogel.
2019. "Urinary Metabolomics Validates Metabolic Differentiation Between Renal Cell Carcinoma Stages and Reveals a Unique Metabolic Profile for Oncocytomas" Metabolites 9, no. 8: 155.
https://doi.org/10.3390/metabo9080155
APA Style
Falegan, O. S., Arnold Egloff, S. A., Zijlstra, A., Hyndman, M. E., & Vogel, H. J.
(2019). Urinary Metabolomics Validates Metabolic Differentiation Between Renal Cell Carcinoma Stages and Reveals a Unique Metabolic Profile for Oncocytomas. Metabolites, 9(8), 155.
https://doi.org/10.3390/metabo9080155